Pfizer, New York, is expected to tap Deutsch
for the estimated $50 million account of antidepressant Zoloft. The win comes after Deutsch captured Pfizer's Zyrtec anti-allergy account last year. Other contenders in the Zoloft direct-to-consumer review included Y&R Advertising, Merkley Newman Harty Healthworks and FCB Worldwide.
Copyright May 2000, Crain Communications Inc.